← Leaderboards
Aneta Joanna Mieszawska
Brooklyn College
$1,547,051
Attributed
$2,623,101
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $524.3K · FY2015–23$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,623,101 · 2
By mechanism
R01$2,152,101 · 1
SC2$471,000 · 1
Top collaborators
- John A Martignetti10 shared
Most similar at Brooklyn College
Same institution · by research overlap
- Roberto A Sanchez-Delgado$1,894,717
Others in their field
Top investigators on “Generations”
- Richard A Gibbs · Baylor College Of Medicine$539,942,150
- David Heimbrook · Leidos Biomedical Research, Inc.$461,253,475
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Dennis R. Burton · Scripps Research Institute$280,469,869
- Eric S Lander · Whitehead Institute For Biomedical Res$262,517,055
Research focus
GenerationsEvaluationExhibitsFluorophoreEncapsulatedEndotheliumCytotoxicDiagnosticDna RepairDoseDrug ResistanceEffectivenessAntineoplastic AgentsBiologicalCancer RelapseClinical InvestigationDiagnosisCancer TherapyChemotherapyDna DamageCancer CellDosageCancer PatientHalf-Life
Grant awards (13)
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$323,970
R01 · FY2023 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$323,970
R01 · FY2022 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$118,979
R01 · FY2022 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$330,582
R01 · FY2021 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$121,408
R01 · FY2021 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$72,341
R01 · FY2021 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$330,582
R01 · FY2020 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$121,408
R01 · FY2020 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$66,737
R01 · FY2020 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$342,124
R01 · FY2019 · CA · contact PI
Theranostic nanoparticles for dual modality cancer therapy$157,000
SC2 · FY2017 · CA · contact PI
Theranostic nanoparticles for dual modality cancer therapy$157,000
SC2 · FY2016 · CA · contact PI
Theranostic nanoparticles for dual modality cancer therapy$157,000
SC2 · FY2015 · CA · contact PI